Algernon Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Algernon Pharmaceuticals's estimated annual revenue is currently $502.5k per year.
- Algernon Pharmaceuticals's estimated revenue per employee is $100,500
- Algernon Pharmaceuticals's total funding is $8.9M.
Employee Data
- Algernon Pharmaceuticals has 5 Employees.
- Algernon Pharmaceuticals grew their employee count by 0% last year.
Algernon Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
Algernon Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $33.4M | 166 | -10% | N/A | N/A |
#2 | $68.8M | 274 | 18% | $942.6M | N/A |
#3 | $23.5M | 117 | 0% | N/A | N/A |
#4 | $1.6M | 16 | 45% | $3.7M | N/A |
#5 | $0.7M | 7 | 0% | N/A | N/A |
#6 | $1.5M | 15 | 15% | N/A | N/A |
#7 | $1.4M | 14 | 17% | N/A | N/A |
#8 | $0.7M | 7 | -12% | N/A | N/A |
#9 | $17.7M | 88 | 24% | N/A | N/A |
#10 | $4.6M | 23 | -56% | N/A | N/A |
What Is Algernon Pharmaceuticals?
Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW | OTCQB: AGNPF) is a clinical-stage pharmaceutical development company. Our unique drug repurposing strategy enables us to discover new therapeutic uses for existing drugs. This business model lowers investment, risk, and research periods while increasing active patent life. Twitter: @AlgernonPharma Facebook: @AlgernonPharmaceuticals
keywords:N/A
$8.9M
Total Funding
5
Number of Employees
$502.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Algernon Pharmaceuticals News
2022-04-19 - This Pharma Stock Has Some Investors Beyond Excited
Algernon Pharmaceuticals Inc. (AGN:CSE - AGNPF:OTCQB - AGN0:XFRA). $5.88 -0.84%. 2022/4/18 4:...
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 5 | 0% | N/A |
#2 | $0.4M | 5 | -89% | N/A |
#3 | $0.1M | 5 | -44% | $2M |
#4 | $0.6M | 5 | 0% | N/A |
#5 | $0.4M | 5 | -37% | N/A |